1-1 of 1
Keywords: NY-ESO1
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder Cancer

Available to Purchase
Subject Area:
Further Areas
Eva Maria Lausenmeyer, Klara Braun, Johannes Breyer, Michael Gierth, Stefan Denzinger, Maximilian Burger, Hans-Ullrich Voelker, Wolfgang Otto
Journal: Urologia Internationalis
Urol Int (2019) 102 (1): 77–82.
https://doi.org/10.1159/000493577
Published Online: 01 November 2018
... to in the content or advertisements. Bladder Cancer Prognostic factors Cancertestis antigens  CTAG1B NY-ESO1 MAGEA3 Bladder cancer is the second most frequent genito-urinary malignancy, with 90% of these tumours being urothelial bladder cancers (UBC). The gold standard for detecting and follow...
View article titled, Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder Cancer
Open the PDF for Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder Cancer in another window